Trademark: 79302490
Word
NORTHWAY SURGICAL CENTER
Status Date
Wednesday, August 24, 2022
Filing Date
Wednesday, October 14, 2020
Published for Opposition
Tuesday, October 26, 2021
Abandoned Date
Wednesday, August 24, 2022
5 Pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological preparations for medical purposes for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19; biological tissue cultures for medical purposes; albuminous preparations for medical purposes, namely, albumin dietary supplements; chemical preparations for medical purposes, namely for the treatment of oncological, cardiovascular, respiratory, inflammatory, autoimmune and degenerative diseases and disorders, rheumatoid arthritis, multiple sclerosis, allergies and COVID-19
44 Medical services; midwife services; alternative medicine services; in vitro fertilization services; chiropractic services; physiotherapy; occupational therapy services; human tissue bank services; hospital services; rental of medical equipment; medical advice for individuals with disabilities; medical clinic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical assistance; opticians' services; plastic surgery; services of a psychologist; convalescent home services; preparation of prescriptions by pharmacists; rehabilitation of substance abuse patients; nursing, medical; health centre services; health counselling; medical screening; health care; telemedicine services
42 Scientific and technological services, namely, research and design in the field of products and processes development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; conducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of manufacture processes for biotechnology products; technological consultation in the field of development of manufacturing processes for biotechnology products
The mark consists of the stylized wording "NORTHWAY" in dark blue, where the "O" is made up of 4 curved bands. The top left and lower right curved bands are orange, the top right and lower left smaller bands are dark blue. Below the letters "RTHWAY" in "NORTHWAY" is the wording "SURGICAL CENTER" in orange.
The color(s) dark blue and orange is/are claimed as a feature of the mark.
"SURGICAL CENTER"
Aug 24, 2023
Final Disposition Notice Sent To Ib
Aug 24, 2023
Final Disposition Notice Created, To Be Sent To Ib
Aug 25, 2022
Abandonment Notice E-Mailed - Inter Partes Decision
Aug 24, 2022
Abandonment - After Inter Partes Decision
Aug 24, 2022
Opposition Terminated No. 999999
Aug 24, 2022
Opposition Dismissed No. 999999
Jul 11, 2022
Notification Of Possible Opposition - Processed By Ib
Jun 23, 2022
Notification Of Possible Opposition Sent To Ib
Jun 22, 2022
Notification Of Possible Opposition Created, To Be Sent To Ib
Dec 6, 2021
Refusal Processed By Ib
Nov 20, 2021
Opposition Instituted No. 999999
Nov 5, 2021
Opposition Papers Received At Ttab
Nov 8, 2021
Opposition Notice (Ib Refusal) Sent To Ib
Nov 6, 2021
Opposition Notice (Ib Refusal) Created
Oct 26, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 26, 2021
Published For Opposition
Oct 6, 2021
Notification Of Notice Of Publication E-Mailed
Sep 22, 2021
Approved For Pub - Principal Register
Sep 21, 2021
Teas/Email Correspondence Entered
Sep 20, 2021
Correspondence Received In Law Office
Sep 20, 2021
Teas Response To Office Action Received
Sep 20, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 20, 2021
Teas Change Of Correspondence Received
Sep 20, 2021
Teas Change Of Domestic Representatives Address
Sep 20, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 20, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 20, 2021
Teas Change Of Owner Address Received
Jul 16, 2021
New Representative At Ib Received
Apr 13, 2021
Refusal Processed By Ib
Mar 25, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Mar 25, 2021
Refusal Processed By Mpu
Mar 20, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Mar 19, 2021
Non-Final Action Written
Mar 15, 2021
Assigned To Examiner
Jan 26, 2021
Application Filing Receipt Mailed
Jan 22, 2021
New Application Office Supplied Data Entered
Jan 21, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
